The six biggest U.S. drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits overseas, almost double what they saved that way 10 years earlier.
Overseas tax savings for U.S. drugmakers under threat
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content